Slide 1: 3rd Quarter 2025 Earnings Release Supplemental Information
10.23.25 3rd Quarter 2025 Earnings Release Supplemental Information
Slide 2: Safe Harbor: Forward Looking Statements
Safe Harbor Forward Looking Statements This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, such as statements about our future plans, objectives, expectations, financial performa
Slide 3: Q3 2025 Year-over-Year
Q3 2025 YEAR-OVER-YEAR Third Quarter Results at Revenue Non-GAAP Diluted EPS* Net Cash Provided by the high end of ($M) ($) Operating Activities ($M) guidance range 52.8 0.33 • Revenue was at the high end of our guided range. 152.9 142.5 0.27 • Non-GAAP Diluted EPS was at the high end of the guided
Slide 4: Q3 2025 Segment Performance: MedTech & Specialty Audio
Q3 2025 SEGMENT PERFORMANCE Revenue Adjusted EBITDA Margin* ($M) (%) MedTech & Specialty Audio 44.1 43.7 63.7 64.7 • Revenue grew year over year on higher demand in specialty audio market. • Adjusted EBITDA margins were down slightly year +1.6% -40 bps over year driven by unfavorable product mix. •
Slide 5: Q3 2025 Segment Performance: Precision Devices
Q3 2025 SEGMENT PERFORMANCE Revenue Adjusted EBITDA Margin* ($M) (%) Precision Devices 88.2 25.7 78.8 23.7 • Revenue was up year over year with strong demand and design wins across all of our end markets - Medtech, Defense, and Industrial. • Adjusted EBITDA margins were up year over year driven by h
Slide 6: Outlook: Q4 2025 Guidance
OUTLOOK Q4 2025 Guidance GAAP Adjustments Non-GAAP Revenues from continuing operations $151 to $161 million $— $151 to $161 million Diluted earnings per share from $0.21 to $0.25 $0.12 $0.33 to $0.37 continuing operations Net cash provided by operating activities $30 to $40 million $— $30 to $40 mil
Slide 7: Appendix
« knowles Appendix
Slide 8: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES Quarter Ended September 30, (continuing operations, in millions, except per share amounts) 2025 2024 Revenues $ 152.9 $ 142.5 Notes Gross profit $ 69.9 $ 62.9 1. Production transfer costs represent duplicate costs incurred to m
Slide 9: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES Quarter Ended September 30, (continuing operations, in millions, except per share amounts) 2025 2024 Notes Net earnings $ 18.0 $ 9.2 5. The non-GAAP reconciling adjustments include stock-based compensation expense, Interest exp
Slide 10: Historical Segment Data
HISTORICAL SEGMENT DATA PRECISION DEVICES MEDTECH & SPECIALTY AUDIO Quarter Ended Quarter Ended September 30, June 30, March 31, December 31, September 30, September 30, June 30, March 31, December 31, September 30, (continuing operations, in millions) 2025 2025 2025 2024 2024 2025 2025 2025 2024 20
Slide 11: Historical Segment Data
HISTORICAL SEGMENT DATA PRECISION DEVICES MEDTECH & SPECIALTY AUDIO Quarter Ended Quarter Ended September 30, June 30, March 31, December 31, September 30, September 30, June 30, March 31, December 31, September 30, (continuing operations, in millions) 2025 2025 2025 2024 2024 2025 2025 2025 2024 20
Slide 12: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES Quarter Ended September 30, June 30, March 31, December 31, September 30, June 30, March 31, December 31, September 30, June 30, March 31, (continuing operations, in millions) 2025 2025 2025 2024 2024 2024 2024 2023 2023 2023 2
Slide 13: Reconciliation of Net Earnings to Adjusted EBITDA
RECONCILIATION OF NET EARNINGS TO ADJUSTED EBITDA Quarter Ended September 30, June 30, March 31, December 31, Trailing (continuing operations, in millions) 2025 2025 2025 2024 12-months Net earnings (loss) $ 18.0 $ 7.8 $ (0.4) $ 10.4 $ 35.8 Interest expense, net 2.3 2.5 2.7 3.4 10.9 Provision for in
Slide 14: Reconciliation of Net Debt
RECONCILIATION OF NET DEBT (in millions) September 30, 2025 Current maturities of long-term debt $ 72.3 Long-term debt 104.0 Total debt 176.3 Less: Cash and cash equivalents (92.5) Net debt $ 83.8 Net debt $ 83.8 Trailing 12 Month Adjusted EBITDA $ 133.6 Net debt leverage ratio 0.6 x 14
Slide 15: Thank you.
Thank you. « knowles